Agile Therapeutics Inc. Stock
Your prediction
Agile Therapeutics Inc. Stock
For the coming years our community has positive and negative things to say abot the Agile Therapeutics Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Innovation" there were negative voices in the community.
Pros and Cons of Agile Therapeutics Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
S********** s********
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Agile Therapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Agile Therapeutics Inc. | - | - | - | - | - | - | - |
| Ardelyx Inc. | 0.260% | -2.416% | -3.297% | 11.041% | -0.745% | 166.985% | -14.652% |
| Krystal Biotech | -1.540% | -2.048% | 11.829% | 26.035% | 31.997% | 166.093% | - |
| Evolus Inc | -1.680% | 2.586% | -0.833% | -45.413% | -43.333% | -8.462% | 63.596% |
Comments
Agile Therapeutics, Inc. (NASDAQ: AGRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for AGRX provided by MarketBeat
Agile Therapeutics, Inc. (NASDAQ: AGRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for AGRX provided by MarketBeat
Agile Therapeutics, Inc. (NASDAQ: AGRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for AGRX provided by MarketBeat